project id: TCGA-CESC; case submitter id: TCGA-EK-A2RM; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.7; rna integrity number: 8.5; age at index: 40; days to birth: -14842; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1969; age at diagnosis: 14842; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 50.0; figo stage: Stage IB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 778; initial weight: 100.0; oct embedded: false; preservation method: Unknown; sample id: f0ca60fb-bd45-4f15-a791-0c5b1218d8ef; sample submitter id: TCGA-EK-A2RM-01A; portion id: b958874a-66ce-40e7-a1c5-82c199d322ba; portion submitter id: TCGA-EK-A2RM-01A-21; slide id: 557023ec-3e2c-493e-9f23-4aa0da611608; slide submitter id: TCGA-EK-A2RM-01A-02-TS2; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 75.0; percent tumor nuclei: 95.0; section location: TOP;